학술논문

Estimated Kidney Tubular Secretion and Kidney, Cardiovascular, and Mortality Outcomes in CKD: The Systolic Blood Pressure Intervention Trial
Document Type
article
Source
Kidney Medicine. 4(12)
Subject
Biomedical and Clinical Sciences
Clinical Sciences
Kidney Disease
Clinical Research
Clinical Trials and Supportive Activities
Prevention
Heart Disease
Cardiovascular
4.1 Discovery and preclinical testing of markers and technologies
Detection
screening and diagnosis
Renal and urogenital
Good Health and Well Being
CKD progression
CVD
hypertension
kidney function decline
mortality
tubular secretion
Clinical sciences
Language
Abstract
Rational & objectiveMany drugs, metabolites, and toxins are cleared by the kidneys via tubular secretion. Whether novel endogenous measures of tubular secretion provide information about kidney, cardiovascular, and mortality risk is uncertain.Study designLongitudinal subgroup analysis of clinical trial participants.Setting & participants2,089 Systolic Blood Pressure Intervention Trial participants with estimated glomerular filtration rate (eGFR) 1 g/d were excluded.ConclusionsAmong SPRINT participants with CKD, lower estimated tubular secretion was associated with faster eGFR decline, independent of baseline eGFR and albuminuria, but not with CKD progression, CVD, or mortality.